AI reads MRIs to spot dangerous prostate cancers before biopsy
NCT ID NCT06842264
First seen Feb 01, 2026 · Last updated May 15, 2026 · Updated 16 times
Summary
This study aims to develop a computer model that uses MRI scans and patient information to predict whether a man has clinically significant prostate cancer (csPCa). Researchers will analyze data from 3,000 men who had an MRI and a prostate biopsy. The goal is to create a tool that helps doctors decide who truly needs a biopsy, reducing unnecessary procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Peking University First Hospital
RECRUITINGBeijing, 100034, China
Conditions
Explore the condition pages connected to this study.